StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
37
This year
5
Publishing Date
2024 - 03 - 21
1
2024 - 03 - 08
1
2024 - 01 - 08
1
2024 - 01 - 04
1
2024 - 01 - 03
1
2023 - 10 - 25
1
2023 - 09 - 25
1
2023 - 09 - 12
1
2023 - 08 - 25
1
2023 - 06 - 26
1
2023 - 05 - 22
1
2023 - 02 - 23
1
2023 - 01 - 19
1
2023 - 01 - 04
1
2022 - 11 - 30
1
2022 - 09 - 16
1
2022 - 08 - 25
1
2022 - 07 - 25
1
2022 - 07 - 11
1
2022 - 07 - 05
1
2022 - 06 - 12
1
2022 - 05 - 11
1
2022 - 04 - 04
1
2022 - 03 - 28
1
2021 - 11 - 12
1
2021 - 11 - 11
1
2021 - 11 - 10
1
2021 - 11 - 04
1
2021 - 09 - 28
1
2021 - 09 - 16
1
2021 - 08 - 05
1
2021 - 07 - 29
1
2021 - 07 - 21
1
2021 - 06 - 22
1
2021 - 06 - 16
1
2021 - 05 - 28
1
2021 - 03 - 22
1
Sector
Consumer durables
1
Consumer non-durables
1
Health technology
37
Tags
Acquired
1
Alcohol use disorder
2
Application
2
Approval
4
Authorization
1
Awiqli
1
Bleeding
3
Children
1
Clearance
1
Diabetes
8
Disease
3
Disorders
1
Drug
1
Ema
1
Europe
2
Expected
2
Fda
2
Fda clearance
1
Fibrosis
1
First
1
Genetown
4
Glargine
1
Global
7
Growing
1
Growth
4
Haemophilia
1
Health
1
Heart
2
Hormone
1
Hypoglycemia
1
Insulin
2
Liver
3
Liver disease
2
Living
1
Market
9
Million
1
Money
2
N/a
28
Nash
1
New drug
1
Obesity
5
Ozempic
1
Patent
1
Pharma
1
Phase 1
3
Phase 2
2
Phase 3
1
Positive
1
Potential
2
Rare
1
Reach
2
Report
4
Research
5
Results
2
Risk
1
Roche
1
Sanofi
1
Sogroya
1
Treatment
34
Trial
7
Entities
Abbvie inc.
3
Abcam plc
1
Alnylam pharmaceuticals, inc.
6
Amgen inc.
2
Amryt pharma plc
1
Apollo endosurgery, inc.
1
Astrazeneca plc
2
Baxter international inc.
1
Bio-techne corp
1
Brunswick corporation
1
Eli lilly and company
9
Glaxosmithkline plc
4
Johnson & johnson
5
Kellogg company
1
Medtronic plc
2
Novartis ag
4
Novo nordisk a/s
37
Omega therapeutics inc
1
Pfizer, inc.
2
Precision biosciences, inc.
1
Sanofi
7
Takeda pharmaceutical company limited
2
Teva pharmaceutical industries ltd
1
Zealand pharma a/s
1
Symbols
ABBV
121
ABT
62
ADIL
22
ALNY
38
ALPMF
52
ALPMY
52
AMGN
47
ARAY
21
ARQT
25
ARWR
21
AZN
52
AZNCF
44
BBIO
20
BHC
36
BIIB
42
BMY
94
BSX
21
BTAI
20
BWAY
41
CHRS
28
CNSP
26
ECL
47
FBIO
27
FNCTF
87
GILD
50
GLAXF
78
GSK
102
HOTH
24
INCY
77
JNJ
211
KPTI
33
LLY
180
MBRX
28
MDT
46
MMM
21
MNOV
24
MRK
66
NTLA
32
NVO
37
NVS
144
NVSEF
120
PFE
75
PHG
21
PRGO
23
RARE
25
REGN
57
RETA
28
RGNX
25
SNY
298
SNYNF
250
SRNE
37
TAK
55
TEVJF
79
TFX
21
TGTX
24
TNXP
32
VRCA
23
VRTX
27
VTRS
46
XYL
35
Exchanges
Nasdaq
20
Nyse
37
Crawled Date
2024 - 03 - 21
1
2024 - 03 - 08
1
2024 - 01 - 08
1
2024 - 01 - 04
1
2024 - 01 - 03
1
2023 - 10 - 25
1
2023 - 09 - 25
1
2023 - 09 - 13
1
2023 - 08 - 25
1
2023 - 06 - 26
1
2023 - 05 - 22
1
2023 - 02 - 23
1
2023 - 01 - 19
1
2023 - 01 - 04
1
2022 - 11 - 30
1
2022 - 09 - 16
1
2022 - 08 - 25
1
2022 - 07 - 25
1
2022 - 07 - 11
1
2022 - 07 - 06
1
2022 - 06 - 12
1
2022 - 05 - 11
1
2022 - 04 - 04
1
2022 - 03 - 28
1
2021 - 11 - 12
1
2021 - 11 - 11
1
2021 - 11 - 10
1
2021 - 11 - 04
1
2021 - 09 - 28
1
2021 - 09 - 16
1
2021 - 08 - 05
1
2021 - 07 - 29
1
2021 - 07 - 21
1
2021 - 06 - 22
1
2021 - 06 - 16
1
2021 - 05 - 28
1
2021 - 03 - 22
1
Crawled Time
00:00
2
02:00
1
07:00
1
11:00
2
11:33
1
12:00
2
12:15
3
13:00
2
14:00
4
15:00
2
16:00
2
17:00
3
20:00
1
20:20
1
21:00
4
22:00
4
23:00
2
Source
www.biospace.com
9
www.globenewswire.com
13
www.prnewswire.com
15
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
treatment
symbols :
Nvo
save search
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
Published:
2024-03-21
(Crawled : 16:00)
- globenewswire.com
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
-3.91%
|
O:
-1.04%
H:
1.6%
C:
0.64%
awiqli
approval
treatment
diabetes
insulin
FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight
Published:
2024-03-08
(Crawled : 20:00)
- prnewswire.com
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
fda
obesity
first
treatment
risk
heart
COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart) in people with type 2 diabetes
Published:
2024-01-08
(Crawled : 13:00)
- globenewswire.com
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
18.19%
|
O:
0.19%
H:
0.34%
C:
0.21%
treatment
glargine
trial
diabetes
insulin
Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases
Published:
2024-01-04
(Crawled : 11:00)
- globenewswire.com
OMGA
|
$2.345
-1.88%
-1.92%
300K
|
|
-12.45%
|
O:
92.31%
H:
20.0%
C:
1.24%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
20.88%
|
O:
1.44%
H:
3.68%
C:
2.4%
treatment
research
therapeutics
Nalu Medical, Inc. Announces $65 Million Equity Financing to Advance Treatment for Chronic Neuropathic Pain
Published:
2024-01-03
(Crawled : 17:00)
- biospace.com/
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
22.67%
|
O:
-0.06%
H:
1.75%
C:
1.54%
million
treatment
Global Bleeding Disorders Treatment Market Surpasses $14 Billion in 2022, Expected to Reach $20.3 Billion by 2028
Published:
2023-10-25
(Crawled : 22:00)
- prnewswire.com
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-7.86%
|
O:
-4.69%
H:
0.69%
C:
-3.18%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
28.56%
|
O:
-1.47%
H:
0.22%
C:
-0.83%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-1.62%
|
O:
0.1%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-12.84%
|
O:
0.09%
H:
0.0%
C:
0.0%
bleeding
expected
reach
disorders
treatment
global
market
Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence
Published:
2023-09-25
(Crawled : 12:00)
- globenewswire.com
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
37.2%
|
O:
-0.44%
H:
0.33%
C:
0.25%
health
Global Oral Proteins and Peptides Market Valued at $1.57 Billion in 2022, Driven by Rising Demand for Oral Treatments
Published:
2023-09-12
(Crawled : 00:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
4.92%
|
O:
0.89%
H:
0.37%
C:
-2.49%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
27.33%
|
O:
-2.21%
H:
1.23%
C:
0.11%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
4.14%
|
O:
-0.22%
H:
0.33%
C:
-1.1%
global
market
Global Obesity Treatment Market Poised to Reach $26.44 Billion by 2028, Fueled by Rising Prevalence and Innovative Interventions
Published:
2023-08-25
(Crawled : 02:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-27.38%
|
O:
-0.06%
H:
1.52%
C:
0.66%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
35.16%
|
O:
-0.34%
H:
1.29%
C:
0.93%
MDT
|
$81.29
0.89%
0.0%
5.2M
|
Health Technology
|
-2.14%
|
O:
-0.98%
H:
1.19%
C:
0.82%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-9.08%
|
O:
0.51%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
14.08%
|
O:
-0.11%
H:
0.44%
C:
-0.22%
obesity
reach
treatment
global
market
Zealand Pharma Submits Marketing Authorization Application for Dasiglucagon for Treatment of Severe Hypoglycemia in Diabetes to the European Medicines Agency
Published:
2023-06-26
(Crawled : 07:00)
- globenewswire.com
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
-21.25%
|
O:
0.25%
H:
0.29%
C:
-1.41%
pharma
authorization
treatment
hypoglycemia
application
diabetes
Novo Nordisk A/S: Oral semaglutide 50 mg achieved 15.1% weight loss (17.4% if all people adhered to treatment) in adults with obesity or overweight in the OASIS 1 trial
Published:
2023-05-22
(Crawled : 15:00)
- globenewswire.com
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
-26.55%
|
O:
-0.04%
H:
0.86%
C:
0.02%
obesity
trial
Worldwide Recombinant Protein Industry to 2027: Elevating Prevalence of Several Chronic Diseases Along With the Increasing Demand for Novel Treatment Options Drives Growth
Published:
2023-02-23
(Crawled : 23:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-4.53%
|
O:
-2.11%
H:
0.0%
C:
0.0%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
-12.34%
|
O:
-1.0%
H:
0.22%
C:
0.1%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-2.62%
|
O:
0.72%
H:
0.0%
C:
0.0%
TECH
|
$63.675
1.39%
1.37%
1.2M
|
Health Technology
|
-15.44%
|
O:
-1.43%
H:
0.25%
C:
-1.0%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
14.43%
|
O:
-0.33%
H:
0.1%
C:
-1.34%
ABCM
|
News
|
$23.99
0.0%
7.4M
|
Health Technology
|
68.0%
|
O:
-0.14%
H:
0.98%
C:
0.0%
treatment
growth
Global Bleeding Disorders Treatment Market Report 2022: Industry Trends, Share, Size, Growth, Opportunities and Forecasts 2021-2027
Published:
2023-01-19
(Crawled : 21:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-6.99%
|
O:
-2.08%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-17.53%
|
O:
-0.19%
H:
0.8%
C:
0.62%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
-10.95%
|
O:
-0.23%
H:
0.56%
C:
0.55%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-12.04%
|
O:
0.34%
H:
0.01%
C:
-0.8%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-6.14%
|
O:
-0.41%
H:
0.0%
C:
0.0%
treatment
bleeding
global
report
market
Global Type 2 Diabetes Treatment Market Outlook Report 2022-2023 & 2027: Patent Cliff, Oral Antidiabetics, and Growing Focus on Accessibility and Affordability of Medicine Bolsters Growth
Published:
2023-01-04
(Crawled : 23:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
0.5%
|
O:
-0.93%
H:
3.08%
C:
3.08%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
-8.42%
|
O:
-0.89%
H:
1.18%
C:
0.52%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
3.19%
|
O:
-0.85%
H:
0.2%
C:
-0.29%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-17.22%
|
O:
-0.62%
H:
0.54%
C:
-0.12%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-6.04%
|
O:
-3.07%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
0.91%
|
O:
-0.49%
H:
1.65%
C:
0.94%
treatment
patent
global
report
growing
diabetes
growth
market
iECURE Raises $65 Million to Advance In Vivo Gene Editing Programs for the Treatment of Rare Pediatric Liver Diseases
Published:
2022-11-30
(Crawled : 14:00)
- biospace.com/
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
3.22%
|
O:
2.1%
H:
0.56%
C:
0.56%
DTIL
|
$10.33
6.72%
6.29%
31K
|
Health Technology
|
644.62%
|
O:
1.54%
H:
4.55%
C:
3.79%
treatment
rare
liver
Global Bleeding Disorders Treatment Market Report 2022: Healthy Growth Expected Driven By Key Players Bayer, Pfizer, Octapharma & Others
Published:
2022-09-16
(Crawled : 16:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
16.59%
|
O:
0.74%
H:
0.91%
C:
-0.74%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
21.36%
|
O:
-1.76%
H:
0.55%
C:
0.03%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
17.38%
|
O:
0.1%
H:
0.25%
C:
-0.21%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
136.32%
|
O:
-0.48%
H:
1.3%
C:
0.3%
BAX
|
$41.02
1.54%
0.0%
2.6M
|
Health Technology
|
-31.49%
|
O:
-0.41%
H:
0.16%
C:
-0.94%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
13.78%
|
O:
-0.52%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
19.44%
|
O:
-0.34%
H:
2.35%
C:
1.87%
treatment
bleeding
global
report
expected
growth
market
Menopausal Hot Flashes Treatment Market Estimated to Rise at CAGR of 6% from 2019 to 2027, TMR Study
Published:
2022-08-25
(Crawled : 14:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
24.27%
|
O:
0.03%
H:
0.0%
C:
-1.29%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-44.63%
|
O:
0.19%
H:
0.9%
C:
0.8%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
13.85%
|
O:
-0.18%
H:
1.45%
C:
1.44%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
13.35%
|
O:
-0.28%
H:
0.13%
C:
0.04%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
21.06%
|
O:
0.0%
H:
0.63%
C:
0.6%
treatment
study
market
Global Acquired von Willebrand Disease (AvWD) Treatment Market Report 2022-2030 Featuring Key Players - Novo Nordisk A/S, Genentech, Inc., F. Hoffman-La Roche AG, Sanofi SA
Published:
2022-07-25
(Crawled : 14:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-5.58%
|
O:
0.0%
H:
0.0%
C:
0.0%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
9.3%
|
O:
0.83%
H:
0.67%
C:
0.32%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-4.02%
|
O:
0.76%
H:
0.19%
C:
-1.06%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-6.4%
|
O:
2.0%
H:
0.0%
C:
0.0%
treatment
global
disease
report
roche
acquired
sanofi
market
Novo Nordisk A/S: Mim8 phase 1 & 2 data demonstrates potential as once monthly treatment for people with haemophilia A
Published:
2022-07-11
(Crawled : 14:00)
- globenewswire.com
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
16.22%
|
O:
1.18%
H:
1.24%
C:
0.45%
treatment
haemophilia
potential
phase 1
Hemophilia Treatment Market to Reach $26.9 Bn, Globally, by 2031 at 7.5% CAGR: Allied Market Research
Published:
2022-07-05
(Crawled : 00:00)
- prnewswire.com
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
14.96%
|
O:
0.28%
H:
1.67%
C:
1.13%
treatment
research
market
← Previous
1
2
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.